RxDoctor Payments Data

Samantha Ruhlen

Nurse Practitioner · Grove City, OHNPI 1366130627

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $5,604 of the $6,931 with a category attached, or 80.9%. It is spread thinly across 49 manufacturers, the largest accounting for just 7.6% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $3,604, 4.4 times the $811 reported in 2023. Among nurse practitioner clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$6,931in general payments, 2019–2025

Across 267 payments — averaging $25.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Incyte Corporation$530
  • Caris MPI, Inc.$519
  • AstraZeneca$399
  • Johnson & Johnson$365
  • AVEO Pharmaceuticals, Inc.$349
  • Merck$326
  • plus $4K from 43 others

What the payments were for

  • Consulting fees$3755%
  • Food & beverage$5,60481%
  • Education$95214%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,931 in reported general payments places this provider in the 95th percentile of 4,700 nurse practitioner providers in Ohio.

See all nurse practitioner providers in Ohio →

Medicare billing

Part B allowed, 2024
$58,389
Medicare patients
77
Services billed
1,942

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
ImbruvicaIbrutinib14$222,634
EliquisApixaban11$7,333
Imatinib Mesylate13$5,105
Letrozole120$2,680
Tamoxifen Citrate46$1,360
Anastrozole40$982
Oxycodone Hcl41$601
Dexamethasone24$470
Ondansetron OdtOndansetron19$344
Prochlorperazine Maleate19$343
Acyclovir13$318
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen15$201
Lidocaine-PrilocaineLidocaine/Prilocaine14$174
Prednisone27$78
Zolpidem Tartrate11$1

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$259$7,33311 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 4,700 nurse practitioner providers in Ohio.

Other nurse practitioner in Grove City

See the full list for Ohio →

Where these figures come from

Is this you, or does something look wrong? →